| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 215,620 | 274,256 | 257,618 | | Cost of Revenue | 138,629 | 171,366 | 155,780 | | | Gross Profit | 76,991 | 102,890 | 101,838 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 95,560 | 105,007 | 95,757 | | Non Recurring | 613 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (19,182) | (2,117) | 6,081 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 205 | | Earnings Before Interest And Taxes | (19,182) | (2,117) | 6,286 | | Interest Expense | 309 | 6 |
-
| | Income Before Tax | (19,491) | (2,123) | 6,286 | | Income Tax Expense | (6,874) | 212 | 532 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,617) | (2,335) | 5,754 | | | Non-recurring Events | | Discontinued Operations | 29,776 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 17,159 | (2,335) | 5,754 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,159 | ($2,335) | $5,754 |
|
0.34% Nasdaq 
0.05 (2.94%) 
Income Statement
